<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               6 ADVERSE REACTIONS<BR>               <BR>                  The adverse reaction profiles for PROTONIX (pantoprazole sodium) For Delayed-Release Oral Suspension and PROTONIX (pantoprazole sodium) Delayed-Release Tablets are similar.<BR>               <BR>               <BR>               <BR>                  <BR>                     <BR>                        The most frequently occurring adverse reactions are as follows:<BR>                        <BR>                           For adult use (>2%) are headache, diarrhea, nausea, abdominal pain, vomiting, flatulence, dizziness, and arthralgia. (6)<BR>                           For pediatric use (>4%) are URI, headache, fever, diarrhea, vomiting, rash, and abdominal pain. (6)<BR>                        <BR>                        <BR>                           To report SUSPECTED ADVERSE REACTIONS, contact Wyeth Pharmaceuticals Inc. at 1-800-934-5556 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch<BR>                        <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     6.1 Clinical Trial Experience<BR>                     <BR>                        Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice.<BR>                     <BR>                     <BR>                     <BR>                        <BR>                           <BR>                           <BR>                           <BR>                              Adults<BR>                           <BR>                           <BR>                              Safety in nine randomized comparative US clinical trials in patients with GERD included 1,473 patients on oral PROTONIX (20 mg or 40 mg), 299 patients on an H2-receptor antagonist, 46 patients on another proton pump inhibitor, and 82 patients on placebo. The most frequently occurring adverse reactions are listed in Table 3.<BR>                              <BR><BR><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" border="1" ID="id_7d72a5f1-e4e5-49d0-8f15-72ea30e12c11"><BR>                                 <caption ID="id_dbef38e7-9c9e-4440-b684-4ea62691d35c">Table 3: Adverse Reactions Reported in Clinical Trials of Adult Patients with GERD at a Frequency of &gt; 2%</caption><BR>                                 <col width="156px"/><BR>                                 <col width="152px"/><BR>                                 <col width="156px"/><BR>                                 <col width="156px"/><BR>                                 <thead><BR>                                    <tr ID="id_83f9dc70-56a1-46e9-a20a-2c2c93cca039" styleCode="Botrule"><BR>                                       <td align="left" valign="bottom" styleCode="Rrule">&#160;</td><BR>                                       <td align="center" valign="bottom" styleCode="Rrule">PROTONIX<br/>(n=1473)<br/>%</td><BR>                                       <td align="center" valign="bottom" styleCode="Rrule">Comparators<br/>(n=345)<br/>%</td><BR>                                       <td align="center" valign="bottom">Placebo<br/>(n=82)<br/>%</td><BR>                                    </tr><BR>                                 </thead><BR>                                 <tbody><BR>                                    <tr ID="id_d566b619-f792-46b4-b798-9ab6cfa22cc5" styleCode="Toprule"><BR>                                       <td align="left" valign="top">Headache</td><BR>                                       <td align="center" valign="top" styleCode="Toprule">12.2</td><BR>                                       <td align="center" valign="top" styleCode="Toprule">12.8</td><BR>                                       <td align="center" valign="top">8.5</td><BR>                                    </tr><BR>                                    <tr ID="id_e1df9ad3-f557-4b77-a43b-cdf81c51afba"><BR>                                       <td align="left" valign="top">Diarrhea</td><BR>                                       <td align="center" valign="top">8.8</td><BR>                                       <td align="center" valign="top">9.6</td><BR>                                       <td align="center" valign="top">4.9</td><BR>                                    </tr><BR>                                    <tr ID="id_618b746c-1ea8-4384-96cc-ce37788eba74"><BR>                                       <td align="left" valign="top">Nausea</td><BR>                                       <td align="center" valign="top">7.0</td><BR>                                       <td align="center" valign="top">5.2</td><BR>                                       <td align="center" valign="top">9.8</td><BR>                                    </tr><BR>                                    <tr ID="id_ebd5cebe-9c2c-4f9c-8776-eae69b39c6a3"><BR>                                       <td align="left" valign="top">Abdominal pain</td><BR>                                       <td align="center" valign="top">6.2</td><BR>                                       <td align="center" valign="top">4.1</td><BR>                                       <td align="center" valign="top">6.1</td><BR>                                    </tr><BR>                                    <tr ID="id_afe5ecf3-1ba9-4769-b0c9-7b6471c827cc"><BR>                                       <td align="left" valign="top">Vomiting</td><BR>                                       <td align="center" valign="top">4.3</td><BR>                                       <td align="center" valign="top">3.5</td><BR>                                       <td align="center" valign="top">2.4</td><BR>                                    </tr><BR>                                    <tr ID="id_05a50306-3c77-4628-8d17-b1674f64f3e4"><BR>                                       <td align="left" valign="top">Flatulence</td><BR>                                       <td align="center" valign="top">3.9</td><BR>                                       <td align="center" valign="top">2.9</td><BR>                                       <td align="center" valign="top">3.7</td><BR>                                    </tr><BR>                                    <tr ID="id_660cc53c-1029-4ccb-9a5d-07453263b08f"><BR>                                       <td align="left" valign="top">Dizziness</td><BR>                                       <td align="center" valign="top">3.0</td><BR>                                       <td align="center" valign="top">2.9</td><BR>                                       <td align="center" valign="top">1.2</td><BR>                                    </tr><BR>                                    <tr ID="id_35c48279-7c51-422e-88a3-bca632c4bf25" styleCode="Botrule"><BR>                                       <td align="left" valign="top">Arthralgia</td><BR>                                       <td align="center" valign="top">2.8</td><BR>                                       <td align="center" valign="top">1.4</td><BR>                                       <td align="center" valign="top">1.2</td><BR>                                    </tr><BR>                                 </tbody><BR>                              </table><BR>                              <BR><BR><BR>Additional adverse reactions that were reported for PROTONIX in clinical trials with a frequency of ≤ 2% are listed below by body system:<BR>                              <BR>                                 Body as a Whole: allergic reaction, pyrexia, photosensitivity reaction, facial edema<BR>                              <BR>                                 Gastrointestinal: constipation, dry mouth, hepatitis<BR>                              <BR>                                 Hematologic: leukopenia, thrombocytopenia<BR>                              <BR>                                 Metabolic/Nutritional: elevated CK (creatine kinase), generalized edema, elevated triglycerides, liver enzymes elevated<BR>                              <BR>                                 Musculoskeletal: myalgia<BR>                              <BR>                                 Nervous: depression, vertigo<BR>                              <BR>                                 Skin and Appendages: urticaria, rash, pruritus<BR>                              <BR>                                 Special Senses: blurred vision<BR>                           <BR>                           <BR>                        <BR>                     <BR>                     <BR>                        <BR>                           <BR>                           <BR>                           <BR>                              Pediatric Patients<BR>                           <BR>                           <BR>                              Safety of PROTONIX in the treatment of Erosive Esophagitis (EE) associated with GERD was evaluated in pediatric patients ages 1 year through 16 years in three clinical trials. Safety trials involved pediatric patients with EE; however, as EE is uncommon in the pediatric population, 249 pediatric patients with endoscopically-proven or symptomatic GERD were also evaluated. All adult adverse reactions to PROTONIX are considered relevant to pediatric patients. In patients ages 1 year through 16 years, the most commonly reported (> 4%) adverse reactions include: URI, headache, fever, diarrhea, vomiting, rash, and abdominal pain. <BR>                              For safety information in patients less than 1 year of age see Use in Specific Populations (<BR>                                 <BR>                                    8.4<BR>                                 <BR>                                 ).<BR>                              Additional adverse reactions that were reported for PROTONIX in pediatric patients in clinical trials with a frequency of ≤ 4% are listed below by body system:<BR>                              <BR>                                 Body as a Whole: allergic reaction, facial edema<BR>                              <BR>                                 Gastrointestinal: constipation, flatulence, nausea<BR>                              <BR>                                 Metabolic/Nutritional: elevated triglycerides, elevated liver enzymes, elevated CK (creatine kinase)<BR>                              <BR>                                 Musculoskeletal: arthralgia, myalgia<BR>                              <BR>                                 Nervous: dizziness, vertigo<BR>                              <BR>                                 Skin and Appendages: urticaria <BR>                              The following adverse reactions seen in adults in clinical trials were not reported in pediatric patients in clinical trials, but are considered relevant to pediatric patients: photosensitivity reaction, dry mouth, hepatitis, thrombocytopenia, generalized edema, depression, pruritus, leukopenia, and blurred vision.<BR>                           <BR>                           <BR>                        <BR>                     <BR>                     <BR>                        <BR>                           <BR>                           <BR>                           <BR>                              Zollinger-Ellison Syndrome<BR>                           <BR>                           <BR>                              In clinical studies of Zollinger-Ellison Syndrome, adverse reactions reported in 35 patients taking PROTONIX 80 mg/day to 240 mg/day for up to 2 years were similar to those reported in adult patients with GERD.<BR>                           <BR>                           <BR>                        <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     6.2 Postmarketing Experience<BR>                     <BR>                        The following adverse reactions have been identified during postapproval use of PROTONIX. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.<BR>                        These adverse reactions are listed below by body system:<BR>                        <BR>                           Immune System Disorders: anaphylaxis (including anaphylactic shock)<BR>                        <BR>                           Skin and Subcutaneous Tissue Disorders: severe dermatologic reactions (some fatal), including erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis (TEN, some fatal), and angioedema (Quincke's edema) <BR>                        <BR>                           Musculoskeletal and Connective Tissue Disorders: rhabdomyolysis, bone fracture<BR>                        <BR>                           Renal and Urinary Disorders: interstitial nephritis <BR>                        <BR>                           Hepatobiliary Disorders: hepatocellular damage leading to jaundice and hepatic failure<BR>                        <BR>                           Psychiatric Disorders: hallucination, confusion<BR>                     <BR>                     <BR>                  <BR>               <BR>            <BR>         </P></DIV></HTML>